DOMS Industries Ltd — Q4 FY26 earnings call
Summary generated by AI from the official transcript DOMS Industries Ltd filed with BSE on 21 May 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
DOMS Industries reported Q4 FY26 revenue growth of 18.7% to Rs 604 crores and full-year FY26 revenue growth of 21.6% to Rs 2,326.4 crores, exceeding its full-year guidance. EBITDA margin for Q4 declined to 16.7% from 17.3% a year earlier, and management attributed this to seasonal slowdown in the baby hygiene segment and higher e-commerce related costs at Uniclan. Management said raw material costs linked to crude derivatives had risen sharply due to the West Asia crisis, and that calibrated pricing actions of about 4% to 5% had been taken so far to partly offset this.
Numbers mentioned
Revenue: INR604 crores (Q4 FY26)
p. 4
“Revenue for Q4 FY26 grew by 18.7% to INR604 crores, highlighting a sustained growth trajectory”
Rahul Shah, page 4 of the filed PDF · View the filing
EBITDA: INR100.9 crores (Q4 FY26)
p. 4
“EBITDA for Q4 FY26 grew by 14.4% to INR100.9 crores with an EBITDA margin at 16.7% in Q4 FY26 as compared to 17.3% in Q4 FY25.”
Rahul Shah, page 4 of the filed PDF · View the filing
PAT: INR58.2 crores (Q4 FY26)
p. 4
“PAT for Q4 FY26 grew by 13.5% to INR58.2 crores and PAT margin for the same period stood at 9.6% compared to 10% in Q4 FY25.”
Rahul Shah, page 4 of the filed PDF · View the filing
Revenue: INR2,326.4 crores (FY26)
p. 4
“Revenue from operations for financial year 2026 grew by 21.6% to INR2,326.4 crores as compared to FY25, surpassing our guided range”
Rahul Shah, page 4 of the filed PDF · View the filing
EBITDA margin: 17.3% (FY26)
p. 4
“The EBITDA margin softened to 17.3% as compared to 18.2% in FY25 on account of higher Uniclan contribution in the overall consolidated operations.”
Rahul Shah, page 4 of the filed PDF · View the filing
PAT: INR239.6 crores (FY26)
p. 5
“PAT for FY26 grew by 12.2% to INR239.6 crores.”
Rahul Shah, page 5 of the filed PDF · View the filing
Capex: INR292 crores (FY26)
p. 5
“The company totally spent around INR292 crores in FY26 towards these objectives.”
Rahul Shah, page 5 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Revenue growth — 17% to 20% · FY27
stated firmly by Rahul Shah
p. 11
“we expect revenue to grow by 17% to 20% in FY27. It's the same guidance that we had in the previous call.”
Rahul Shah, page 11 of the filed PDF · View the filing
Capex — INR250 crores to INR275 crores · FY27
stated firmly by Rahul Shah
p. 5
“we have lined up a capex plan between INR250 crores to INR275 crores for FY27.”
Rahul Shah, page 5 of the filed PDF · View the filing
45-acre plant first building completion — June 2027
stated firmly by Rahul Shah
p. 5
“the first building is on track for completion in June 2027 with commercial production expected to commence towards the end of Q2 FY27.”
Rahul Shah, page 5 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said the growth was not due to channel stocking and reflected back-to-school seasonal demand.
Answered by Management
Asked by Aradhana Jain: Was Q4 core stationery growth of 19% driven by channel stocking ahead of price increases or by underlying demand?
p. 6
“This was not a part of any channel stocking or anything because we closely monitor our primary sales vis-a-vis, the primary and our secondary sales.”
Management, page 6 of the filed PDF · View the filing
Management said raw material costs had risen 15-17% versus 4-5% pricing action taken, creating a near-term gap, but described the impact as temporary rather than structural.
Answered by Management
Asked by Aradhana Jain: If the geopolitical situation sustains, will EBITDA margins take a hit versus the 16.5-17.5% guided band?
p. 6
“On an average, we have seen our raw material cost increase by approximately 15% to 17%, while the pricing actions taken so far are around 4% to 5%, which naturally creates a near-term gap.”
Management, page 6 of the filed PDF · View the filing
Management said a similar 4-5% price increase was taken at that time across impacted products, following a calibrated, phased approach.
Answered by Rahul Shah
Asked by Percy Panthaki: What price increases were taken during the Ukraine war inflation period compared to the current 4-5%?
p. 8
“at that point of time also, we've taken about 4% to 5% increase across the impacted products.”
Rahul Shah, page 8 of the filed PDF · View the filing
Management said roughly 40% of the RM basket has direct crude linkage, 30% indirect, and gave a breakdown of the INR377 crore inventory.
Answered by Management
Asked by Jinesh Joshi: What proportion of the raw material basket is crude-linked, and how much RM inventory is on the balance sheet?
p. 9
“which would be roughly about 40-odd percent, then there is about 30%, which is indirect linkage.”
Management, page 9 of the filed PDF · View the filing
Management attributed the EBITDA compression to higher e-commerce related costs in the Uniclan baby hygiene business.
Answered by Management
Asked by Jinesh Joshi: Why did EBITDA margin compress despite stable gross margins in the quarter?
p. 10
“gross margins for the quarter were largely steady, but EBITDA declined due to higher operating costs.”
Management, page 10 of the filed PDF · View the filing
Management confirmed FY27 revenue growth guidance of 17% to 20%, unchanged from the previous call.
Answered by Rahul Shah
Asked by Sneha: Is the company maintaining its 20% topline growth guidance for the next 1-2 years?
p. 11
“we expect revenue to grow by 17% to 20% in FY27. It's the same guidance that we had in the previous call.”
Rahul Shah, page 11 of the filed PDF · View the filing
Management said Uniclan FY26 revenue was INR203 crores with margins around 8.6%, and expects margins to stabilize near 10% long term.
Answered by Management
Asked by Kunal Vora: What is the FY26 Uniclan revenue and margin, and outlook for FY27?
p. 14
“So, FY26 on a full year basis, we've done a revenue of around INR203 crores at Uniclan.”
Management, page 14 of the filed PDF · View the filing
Management confirmed the guidance already factors in gradual ramp-up of the new plant capacities from H1/H2 FY27.
Answered by Rahul Shah
Asked by Priyank Chheda: Does the FY27 revenue guidance of 17-20% already include the new 45-acre plant capacity coming online in H2?
p. 16
“this is an annual guidance of close to 17% to 20%, which includes the new capacities coming in from H1 for the new plant.”
Rahul Shah, page 16 of the filed PDF · View the filing
Management said the total project capex, from land purchase through full plant development, would be close to INR850-1,000 crores.
Answered by Management
Asked by Priyank Chheda: What is the total capex for the 45-acre project including land and construction versus the earlier guided INR450 crores?
p. 16
“the total capex would be close to INR850 crores to INR1,000 crores.”
Management, page 16 of the filed PDF · View the filing
Risks flagged
Seasonal slowdown in baby hygiene segment impacting fixed cost absorption
p. 4
“The moderation in EBITDA margin is partly due to the onset of the seasonal slowdown in the baby hygiene segment, which impacted fixed cost absorption.”
Rahul Shah, page 4 of the filed PDF · View the filing
Global uncertainty including trade tensions, geopolitical conflicts and regional instability affecting exports
p. 4
“exports also delivered steady double-digit growth despite global uncertainties, including trade tensions, geopolitical conflicts and regional instability”
Rahul Shah, page 4 of the filed PDF · View the filing
Aggressive pricing moves risk loss of shelf space to competitors and new entrants
p. 8
“whenever we've taken aggressive pricing moves, can sometimes lead to loss of shelf space to new entrants and existing competitors.”
Rahul Shah, page 8 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.